Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out

Executive Summary

Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year

You may also be interested in...



Patent Placement Can Impact Compound Value; Is Pfizer Finding Irish Gold?

Companies acquiring intellectual property should give keen consideration to where the IP is best housed, Celtic Pharma CEO Stephen Evans-Freke said

Patent Placement Can Impact Compound Value; Is Pfizer Finding Irish Gold?

Companies acquiring intellectual property should give keen consideration to where the IP is best housed, Celtic Pharma CEO Stephen Evans-Freke said

Rx Firms Can Use Repatriated Cash On Marketing, Mergers

The Treasury Department and Internal Revenue Service will allow manufacturers to use repatriated cash from overseas operations on marketing expenses and mergers

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel